Search results
Pages
-
- Clinical evaluation of the clinicopathologic and gene expression profile (CP-GEP) in patients with melanoma eligible for sentinel lymph node biopsy
-
- Increased histological tumor pigmentation in uveal melanoma is related to eye color and loss of chromosome 3/BAP1
-
- Response to checkpoint inhibition and targeted therapy in melanoma patients with concurrent haematological malignancies
-
- Conversion of unresponsiveness to immune checkpoint inhibition by fecal microbiota transplantation in patients with metastatic melanoma
-
- Single agent Talimogene Laherparepvec for stage IIIB-IVM1c melanoma patients: A systematic review and meta-analysis
-
- Does Tc-99m-tilmanocept, as next generation radiotracer, meet with the requirements for improved sentinel node imaging?
-
- Birth cohort-specific trends of sun-related behaviors among individuals from an international consortium of melanoma-prone families
-
- Clinical outcome of patients with metastatic melanoma of unknown primary in the era of novel therapy
-
- Early discontinuation of PD-1 blockade upon achieving a complete or partial response in patients with advanced melanoma